Department of Neuroscience, The Ohio State University, Wexner Medical Center, United States.
Division of Biosciences, The Ohio State University College of Dentistry, United States; Institute for Behavioral Medicine Research, The Ohio State University, Wexner Medical Center, United States.
Brain Behav Immun. 2024 Jan;115:356-373. doi: 10.1016/j.bbi.2023.10.011. Epub 2023 Oct 31.
Chronic stress is linked to increased anxiety. Repeated social defeat (RSD) in mice causes anxiety that is dependent on activated neurons, reactive microglia, and accumulation of monocytes in the brain. This response requires interactions between the immune system and central nervous system (CNS). Neuronal activation within threat appraisal regions is a key response to RSD, however, it is unclear how microglia become activated. One potential explanation is that microglia express a purinergic non-selective ligand gated adenosine-triphosphate (ATP) receptor 7 (P2X7). Activation of P2X7 promotes the release of chemokines and cytokines, and recruitment of monocytes to the brain. Thus, the purpose of this study was to determine if a novel P2X7 antagonist blocked neuronal and microglia interactions and the corresponding anxiety following RSD. Male mice were administered (i.p.) a P2X7 antagonist, JNJ-54471300, prior to each cycle of RSD. Fourteen hours after RSD, behavioral deficits including social avoidance and anxiety-like were determined. Moreover, several immune parameters were assessed. RSD caused neuronal activation in stress-responsive regions, monocyte production and release, splenomegaly, and social avoidance. These parameters were unaffected by P2X7 antagonism. RSD-associated proportional area of Iba-1+ microglia, monocyte accumulation in the brain, IL-1β mRNA expression in enriched myeloid cells, plasma IL-6, and anxiety-like behavior were ameliorated by P2X7 antagonism. Gene expression analysis in the hippocampus and amygdala showed regional specific responses to RSD and some were reversed with P2X7 antagonism. Overall, blocking P2X7 activation attenuated RSD-induced microglia reactivity with corresponding reduction in neuroinflammation, monocyte accumulation, and anxiety-like behavior in male mice.
慢性应激与焦虑增加有关。在小鼠中,反复的社交挫败(RSD)会导致依赖于激活神经元、反应性小胶质细胞和单核细胞在大脑中积累的焦虑。这种反应需要免疫系统和中枢神经系统(CNS)之间的相互作用。威胁评估区域内神经元的激活是对 RSD 的关键反应,然而,小胶质细胞如何被激活尚不清楚。一种潜在的解释是,小胶质细胞表达嘌呤能非选择性配体门控三磷酸腺苷(ATP)受体 7(P2X7)。P2X7 的激活促进趋化因子和细胞因子的释放,并将单核细胞募集到大脑中。因此,本研究的目的是确定一种新型 P2X7 拮抗剂是否能阻断神经元和小胶质细胞的相互作用以及随后的 RSD 引起的焦虑。雄性小鼠在每次 RSD 循环前(i.p.)给予 P2X7 拮抗剂 JNJ-54471300。在 RSD 后 14 小时,确定了包括社交回避和焦虑样行为在内的行为缺陷。此外,还评估了几个免疫参数。RSD 导致应激反应区域的神经元激活、单核细胞的产生和释放、脾脏肿大和社交回避。这些参数不受 P2X7 拮抗作用的影响。RSD 相关的 Iba-1+小胶质细胞的比例区域、大脑中的单核细胞积累、富集髓样细胞中的 IL-1βmRNA 表达、血浆 IL-6 和焦虑样行为,都被 P2X7 拮抗作用改善了。海马和杏仁核中的基因表达分析显示,RSD 引起了区域特异性反应,其中一些反应被 P2X7 拮抗作用逆转。总的来说,阻断 P2X7 的激活减轻了 RSD 引起的小胶质细胞反应性,相应地减少了神经炎症、单核细胞积累和雄性小鼠的焦虑样行为。